02591.HK
Guangzhou Innogen Pharmaceutl Grp Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.60
−0.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 11.26x
- P/S forward
- 17.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.45x
- Price / sales
- 6.61x
- Price / cash flow
- -2.65x
Enterprise value
- Enterprise value
- HKD 572.7M
- EV / sales
- 2.38x
- EV / EBITDA
- -0.93x
- EV / EBIT
- -0.92x
- Market cap
- HKD 1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026